Technology and product review Biatain® Silicone dressings: A case series evaluation


“The majority of healthcare


practitioners were highly impressed with the Biatain® Silicone dressings in terms of ease of


application, ability to absorb exudate, ability to stay in place, ability to conform to the


wound bed and ease of removal.”


irritation, including inflammation, redness and raised edges. Ulcer size was 41 × 9 mm at inclusion. During this study the patient received Biatain Silicone Lite dressing [Figure 11B]. He found the dressing very comfortable to use. The dressing showed good absorption of exudate [Figure 11C]; this was worn for two days and all dressings changes were routine. After six dressing changes, the wound showed evidence of reduced inflammation and redness of the surrounding skin had improved [Figure 11D]. The dressing was very easy to apply and stayed in place during wear time. The dressing conformability was very good and the dressing was very easy to remove. At the final evaluation, the patient said he would like to continue using this dressing.


Case study 3 – leg ulcer This was a 76-year-old woman with a moderately exuding mixed venous/arterial leg ulcer. The wound duration was 10 weeks and it measured 37 × 28 mm at baseline [Figure 12A]. The base of the ulcer showed the partial presence of fibrin and the periwound skin was normal. The patient received Biatain Silicone [Figure 12B] and graduated, multilayer compression bandaging. All dressing changes during the study period were routine. After two weeks of treatment the wound showed good progress with a reduction in size from 37 x 28mm to 34 x 25mm and the wound bed was 100% granulating. At three weeks the wound had further reduced in size to


[A] [B]


28 x 18mm [Figure 12C]. The wound continued to heal after the conclusion of the study and was completely healed at seven weeks. The dressing was very easy to apply and remove, had good absorption capacity [Figure 12D] and conformed very well to the wound bed. The patient found the dressing very comfortable.


CONCLUSION In this case series study based on a product evaluation of Biatain Silicone and Biatain Silicone Lite dressings, the primary endpoint (understanding HCPs’ experience with handling the product) and secondary endpoint (understanding patient experience of wearing the dressing) were achieved. The seven HCPs assessing a total of 39 study


participants with leg ulcers, pressure ulcers, diabetic foot ulcers or donor site wounds all found that the overall performance of the Biatain products was better than that of previously used dressings (which were mainly alginate/Hydrofiber and foam). The majority of HCPs were highly impressed with the Biatain Silicone dressings in terms of ease of application, ability to absorb exudate, ability to stay in place, ability to conform to the wound bed and ease of removal. In addition, the patient experience was shown to be good with 87% responding that they found the dressing very comfortable or comfortable to wear. All HCPs stated that they would use the Biatain Silicone dressings again. n


[C] [D]


AUTHOR DETAILS Chadwick P, Principal Podiatrist, Salford Royal NHS Foundation Trust, Salford, UK. Barrett S, Tissue Viability Lead Nurse, Humber NHS Foundation Trust, Hessle, Hull, UK. Cartier H, Consultant Dermatologist, Centre Medical Saint-Jean, Arras, France. García- Martínez ML, Head, Department of Plastic Surgery Department, University Hospital of Salamanca, Spain. Greco A, Consultant Dermatologist, Outpatient Wound Care Centre, Spaziani Hospital, Frosinone, Italy. Lázaro Martínez JL, Head, University Podiatry Clinic, University Complutense, Madrid, Spain. Drouard-Segard M, Consultant Dermatologist, Hôpital Huriez, Lille, France.


Figure 12. Case study 3 – leg ulcer. [A] Wound at baseline, [B] after application of Biatain® Silicone, [C] after three weeks of treatment, with evidence of wound healing and [D] dressing removal.


24


ACKNOWLEDGEMENTS This study was funded by Coloplast A/S. The results presented are based on questionnaire responses provided by the healthcare practitioners who undertook the case series evaluation, identified as the authors of this article. Medical writing services were provided by Wounds International and Maibritt Bansholm Andersen (Coloplast).


Wounds International Vol 5 | Issue 1 | ©Wounds International 2014 | www.woundsinternational.com


Technology update


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30